Technologies and Equity Investment
Quest is an Alberta based biotechnology company developing and commercializing products to improve the quality of life.
Targeted Cancer Therapy: MAb AR9.6
- US territory licensed to Oncocare Therapeutics
- MAb AR9.6 against truncated MUC 16 for pancreatic cancer
Mutant EGF for Dermatology and Wound Healing
- Licensed from Stanford University
- Target indication: Wound healing